Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.180
-0.220 (-6.47%)
Jan 30, 2026, 4:00 PM EST - Market closed
Evaxion Market Cap
Evaxion has a market cap or net worth of $26.52 million as of February 2, 2026. Its market cap has increased by 587.12% in one year.
Market Cap
26.52M
Enterprise Value
15.95M
1-Year Change
587.12%
Ranking
Category
Stock Price
$3.18
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $26.52M, a decrease of -86.19%. That is a compound annual growth rate of -32.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 26.52M | -33.33% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | 191.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AEON Biopharma | 28.59M |
| Marker Therapeutics | 27.34M |
| Rallybio | 27.14M |
| Palatin Technologies | 26.97M |
| Exicure | 26.93M |
| BriaCell Therapeutics | 26.89M |
| Daré Bioscience | 26.86M |
| Senti Biosciences | 26.69M |